ETF PRO AINovember 17, 2026
BBH VanEck Biotech ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$535Mfund assets
+31.5%return, YTD
—return, 1 year
+$25Mnet flow, 1 month
+$39Mnet flow, 1 year
22.9%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
| 1 | AMGN AMGEN | 16.85% |
| 2 | GILD GILEAD SCIENCES | 14.37% |
| 3 | VRTX VERTEX PHARMACEUTICALS | 8.18% |
| 4 | REGN REGENERON PHARMACEUTICALS | 7.92% |
| 5 | MRNA MODERNA | 6.80% |
| 6 | ARGX ARGENX SE | 4.44% |
| 7 | IQV IQVIA HOLDINGS | 4.26% |
| 8 | NTRA NATERA | 3.69% |
| 9 | RVMD REVOLUTION MEDICINES | 3.42% |
| 10 | ONC BeiGene | 3.04% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS